- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
WISDOM Study Aims to Personalize Breast Cancer Screening
The study plans to evaluate the impact of a personalized approach to breast cancer screening over an annual mammogram.
Laura Esserman, professor in the Department of Surgery and Radiology at the UCSF Helen Diller Comprehensive Cancer Center has always been an out-of-the-box thinker. Now, as she leads the Athena Breast Health Network, they are ready to launch the WISDOM (Women Informed to Screen Depending on Measures of Risk) study, which will evaluate the impact of a personalized approach to breast cancer screening over an annual mammogram.
As October, the Breast Cancer Awareness Month, rolls in Dr Esserman lists some important information about breast cancer to improve women's understanding of the disease:
- Breast cancer isn't 1 disease
- Not all breast cancer is life threatening
- Not everyone needs the same approach to screening
- Consider participating in a clinical trial
- Precision medicine is promising.
"The essence of precision medicine is being able to tailor treatment to biology, patient preference and clinical performance," according to Esserman.
Read more here.
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More
